To the Editor: As rheumatologists who have examined and evaluateda combined total of more than 3000 symptomatic women with siliconebreast implants, we feel compelled to point out the shortcomingsof the study by Gabriel et al. (June 16 issue).1 This studyaddresses only classic connective-tissue diseases, such as systemiclupus erythematosus, rheumatoid arthritis, Sjogren's syndrome,and scleroderma, and appropriately concludes that it is unlikelythat common rheumatic diseases, such as rheumatoid arthritis,are associated with implants. The sample size is inadequateto assess the frequency of uncommon rheumatic diseases, suchas systemic lupus erythematosus or scleroderma, and the . . . [Full Text of this Article]
Romanelli, J. N., Solomon, G., Silverman, S., Espinoza, L.
(1995). More on Breast Implants and Connective-Tissue Diseases. NEJM
332: 1306-1308
[Full Text]